Articles Tagged with deep vein thrombosis

Published on:

NOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.

DVT and hip surgeryPostoperative deep vein thrombosis (DVT) can be a significant problem after a Stryker hip revision surgery, leading to lethal complications. Many times, DVT is challenging to diagnose because classic clinical symptoms and signs are not always present. If the doctor is not suspicious or curious of obvious lacking signs, the individual can develop significantly serious problems, which could lead to death.

In 2009, the Stryker orthopedic medical device company began marketing its Rejuvenate and ABG II modular hip replacement systems. Originally, the hip implants were thought to be far superior to traditional metal-on-metal hip replacement devices. Unfortunately, by July 2012, Stryker voluntarily recalled their hip replacement systems due to significant issues including injury and death related to DVT and other medical problems.

Client Reviews

★★★★★
My family feels a sense of closure with the help of the attorneys at the Drug Law Center. They did a tremendous job.

About the Drug Law Center

The Drug Law Center is sponsored by lawyers who represent individuals and families who have suffered a serious injury or death from a dangerous drug or medical device. While these medical inventions have been marketed to improve the quality of life for people, unsafe drugs and poorly designed medical devices can drastically reduce the quality of life for the individual and his or her family.